Back to top

WARRANT AMENDMENT AGREEMENT

Warrant Agreement

WARRANT AMENDMENT AGREEMENT | Document Parties: Caduceus Capital Master Fund Limited | Europa International, Inc | HBV GP, LLC | Knoll Capital Fund II Master Fund, Ltd | Novelos Therapeutics, Inc | PW Eucalyptus Fund, Ltd | UBS Eucalyptus Fund, LLC | Xmark JV Investment Partners, LLC | Xmark Opportunity Fund, Ltd You are currently viewing:
This Warrant Agreement involves

Caduceus Capital Master Fund Limited | Europa International, Inc | HBV GP, LLC | Knoll Capital Fund II Master Fund, Ltd | Novelos Therapeutics, Inc | PW Eucalyptus Fund, Ltd | UBS Eucalyptus Fund, LLC | Xmark JV Investment Partners, LLC | Xmark Opportunity Fund, Ltd

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: WARRANT AMENDMENT AGREEMENT
Date: 4/14/2008

WARRANT AMENDMENT AGREEMENT, Parties: caduceus capital master fund limited , europa international  inc , hbv gp  llc , knoll capital fund ii master fund  ltd , novelos therapeutics  inc , pw eucalyptus fund  ltd , ubs eucalyptus fund  llc , xmark jv investment partners  llc , xmark opportunity fund  ltd
50 of the Top 250 law firms use our Products every day

WARRANT AMENDMENT AGREEMENT

THIS WARRANT AMENDMENT AGREEMENT (“ Amendment ”) is made as of this 11th day of April, 2008 by and among Novelos Therapeutics, Inc., a Delaware corporation (the “ Company ”) and the undersigned holders of warrants to purchase 7,500,000 shares of the Company’s common stock dated May 2, 2007 (the “ Series B Warrants ”) issued pursuant a certain Securities Purchase Agreement, dated as of April 12, 2007, by and among the Corporation and the Investors signatory thereto (as amended on May 2, 2007, the “ Series B   Purchase Agreement ”). All capitalized terms used but not defined herein shall have the meanings ascribed thereto in the Series B Warrants.
 
WHEREAS, pursuant to Section 21 of the Series B Warrants, the Series B Warrants may amended with the written consent of the Company and the Requisite Holders (as such term is defined in the Series B Purchase Agreement) and any such amendment shall apply to all of the Series B Warrants; and

WHEREAS , the Company and the undersigned holders of Series B Warrants, which holders include the Requisite Holders, desire to amend the Series B Warrants;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree that the Series B Warrants are hereby amended as follows:

1)   The Expiration Date, as defined in Paragraph 1, is hereby changed to April 11, 2013 from May 2, 2012.

2)   The Warrant Price, as defined in Paragraph 1 is hereby reduced to $0.65 from $1.25.

3)   Section 7 is amended and restated as follows:

Section 7.   Reservation of Common Stock . The Corporation hereby represents and warrants that there have been reserved, and the Corporation shall at all applicable times keep reserved until issued (if necessary) as contemplated by this Section 7, out of the authorized and unissued shares of Common Stock, 100% of the number of shares issuable upon exercise of the rights of purchase represented by this Warrant. The Corporation agrees that all Warrant Shares issued upon due exercise of the Warrant shall be, at the time of delivery of the certificates for such Warrant Shares, duly authorized, validly issued, fully paid and non-assessable shares of Common Stock of the Corporation.
 
 
 


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more